ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625507 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625507; 2) Community: the network communities that were significantly associated with the response to NSC 625507; 3) Molecule: the relationships between components within communities and NSC 625507; 4) MDR: the compounds that were significantly associated with the NSC 625507.

NSC Compound Enrichment Correlation
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.013789112253851 0.56331425
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.013789112253851 -0.41700217
NSC 622696 Thioperoxydicarbonic diamide, tetramethyl- 0.013789112253851 0.61906742
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.013789112253851 0.63771712
NSC 638241 Null 0.013789112253851 0.61666673
NSC 638279 Null 0.013789112253851 0.53783839
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.013789112253851 0.5330486
NSC 658143 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin 0.013789112253851 0.50790156
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.013789112253851 0.62640296
NSC 665622 Cyclohexanone, 2,6-bis[(1-pyrrolidinyl)methyl]-, dihydrochloride 0.013789112253851 0.56072069
Total:151  Current:77    [First] [Prev] [Next] [Last]